ORIGINAL RESEARCH article
Front. Cell Dev. Biol., 05 February 2021
Sec. Cell Death and Survival
Volume 8 - 2020 | https://doi.org/10.3389/fcell.2020.610097
RETRACTED: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway
- LW
Li-Mei Wu 1â€
- XL
Xiao-Zhong Liao 2â€
- YZ
Yan Zhang 1â€
- ZH
Zi-Rui He 1
- SN
Shi-Qing Nie 1
- BK
Bin Ke 3
- LS
Lin Shi 4
- JZ
Jian-Fu Zhao 1*
- WC
Wen-Hui Chen 1*
1. Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou, China
2. Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
3. Department of Traditional Chinese Medicine, Cancer Center of Sun Yat-sen University, Guangzhou, China
4. Department of Traditional Chinese Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China
Summary
Citation
Wu L-M, Liao X-Z, Zhang Y, He Z-R, Nie S-Q, Ke B, Shi L, Zhao J-F and Chen W-H (2021) RETRACTED: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway. Front. Cell Dev. Biol. 8:610097. doi: 10.3389/fcell.2020.610097
Received
25 September 2020
Accepted
30 November 2020
Published
05 February 2021
Volume
8 - 2020
Edited by
Inna N. Lavrik, University Hospital Magdeburg, Germany
Reviewed by
Jiaxing Zhang, Sun Yat-sen University, China; Mario Cioce, Campus Bio-Medico University, Italy
Updates
This article was submitted to Cell Death and Survival, a section of the journal Frontiers in Cell and Developmental Biology
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.